Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Boehringer Ingelheim
Medtronic
McKesson
Moodys

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RIFAXIMIN

See Plans and Pricing

« Back to Dashboard

Clinical Trials for rifaximin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00098384 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Completed The University of Texas Health Science Center, Houston Phase 2 2003-06-01 The purpose of this study is to evaluate the effectiveness of poorly absorbed rifaximin in the prevention of travelers' diarrhea among U.S. college students in Mexico for five weeks.
NCT00098384 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Completed Valeant Pharmaceuticals International, Inc. Phase 2 2003-06-01 The purpose of this study is to evaluate the effectiveness of poorly absorbed rifaximin in the prevention of travelers' diarrhea among U.S. college students in Mexico for five weeks.
NCT00098384 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Completed DuPont, Hurbert L., MD Phase 2 2003-06-01 The purpose of this study is to evaluate the effectiveness of poorly absorbed rifaximin in the prevention of travelers' diarrhea among U.S. college students in Mexico for five weeks.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for rifaximin

Condition Name

Condition Name for rifaximin
Intervention Trials
Hepatic Encephalopathy 19
Liver Cirrhosis 13
Cirrhosis 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for rifaximin
Intervention Trials
Hepatic Encephalopathy 26
Brain Diseases 26
Liver Cirrhosis 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for rifaximin

Trials by Country

Trials by Country for rifaximin
Location Trials
United States 373
Italy 11
China 10
United Kingdom 8
Germany 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for rifaximin
Location Trials
California 21
New York 20
Florida 15
Virginia 15
Texas 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for rifaximin

Clinical Trial Phase

Clinical Trial Phase for rifaximin
Clinical Trial Phase Trials
Phase 4 24
Phase 3 26
Phase 2/Phase 3 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for rifaximin
Clinical Trial Phase Trials
Completed 46
Recruiting 43
Not yet recruiting 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for rifaximin

Sponsor Name

Sponsor Name for rifaximin
Sponsor Trials
Valeant Pharmaceuticals International, Inc. 33
Alfasigma S.p.A. 4
Shanghai Zhongshan Hospital 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for rifaximin
Sponsor Trials
Other 147
Industry 47
U.S. Fed 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Merck
Dow
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.